Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation

Tuberculosis (TB) is prevalent throughout the world and is a major public health problem in most developing countries. In India, standardised and Directly Observed Treatment (DOT) under National Tuberculosis Elimination Programme (NTEP) is being recommended currently for drug-sensitive pulmonary TB....

Full description

Bibliographic Details
Main Authors: Yashika Bansal, Nitin Tangri
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/19102/67726_CE[Ra1]_F(IS)_PF1(KB_SS_OM)_PF_NC(KM)_Ref_Pat(OM)_PN(KM).pdf
_version_ 1797294805844230144
author Yashika Bansal
Nitin Tangri
author_facet Yashika Bansal
Nitin Tangri
author_sort Yashika Bansal
collection DOAJ
description Tuberculosis (TB) is prevalent throughout the world and is a major public health problem in most developing countries. In India, standardised and Directly Observed Treatment (DOT) under National Tuberculosis Elimination Programme (NTEP) is being recommended currently for drug-sensitive pulmonary TB. TB being a major health issue in developing nations like India, causes enormous death and morbidity every year. Anti-Tuberculosis Treatment (ATT) given for TB has been highly effective in fighting the disease and is generally well tolerated, with few minor side-effects. We report a 76-year-old male who was diagnosed with pulmonary TB and was on first-line four-drug anti-tubercular therapy ATT since seven days. He presented to the emergency department with loss of weight and appetite, chest tightness and vomiting. Liver Function Tests (LFT) was deranged, suggesting ATT-induced hepatitis. After normalisation of LFT, rifampicin reintroduction was initiated. Complete Blood Count (CBC) revealed pancytopenia. In bone marrow biopsy, normoblastic maturation with few micronormoblasts and megaloblast picture was seen that did not reveal any granuloma, thereby ruling out the presence of Mycobacterium tuberculosis (MTB). Iron profile and vitamin B12 levels were within normal limits. Rifampicin-induced pancytopenia is rare but its possibility should always be kept in mind while treating with ATT.
first_indexed 2024-03-07T21:37:58Z
format Article
id doaj.art-cae7443355984f7f993dd32e23c24b78
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-03-07T21:37:58Z
publishDate 2024-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-cae7443355984f7f993dd32e23c24b782024-02-26T11:51:37ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2024-03-011803010210.7860/JCDR/2024/67726.19102Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare PresentationYashika Bansal0Nitin Tangri1Postgraduate Resident, Department of Respiratory Medicine, Adesh Medical College and Hospital, Shahabad (M), Kurukshetra, Haryana, India.Professor, Deptartment of Respiratory Medicine, Adesh Medical College and Hospital, Shahabad (M), Kurukshetra, Haryana, India.Tuberculosis (TB) is prevalent throughout the world and is a major public health problem in most developing countries. In India, standardised and Directly Observed Treatment (DOT) under National Tuberculosis Elimination Programme (NTEP) is being recommended currently for drug-sensitive pulmonary TB. TB being a major health issue in developing nations like India, causes enormous death and morbidity every year. Anti-Tuberculosis Treatment (ATT) given for TB has been highly effective in fighting the disease and is generally well tolerated, with few minor side-effects. We report a 76-year-old male who was diagnosed with pulmonary TB and was on first-line four-drug anti-tubercular therapy ATT since seven days. He presented to the emergency department with loss of weight and appetite, chest tightness and vomiting. Liver Function Tests (LFT) was deranged, suggesting ATT-induced hepatitis. After normalisation of LFT, rifampicin reintroduction was initiated. Complete Blood Count (CBC) revealed pancytopenia. In bone marrow biopsy, normoblastic maturation with few micronormoblasts and megaloblast picture was seen that did not reveal any granuloma, thereby ruling out the presence of Mycobacterium tuberculosis (MTB). Iron profile and vitamin B12 levels were within normal limits. Rifampicin-induced pancytopenia is rare but its possibility should always be kept in mind while treating with ATT.https://www.jcdr.net/articles/PDF/19102/67726_CE[Ra1]_F(IS)_PF1(KB_SS_OM)_PF_NC(KM)_Ref_Pat(OM)_PN(KM).pdfanti-tuberculosis treatmentdirectly observed treatmentdrug-induced reactionmycobacterium tuberculosis
spellingShingle Yashika Bansal
Nitin Tangri
Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
Journal of Clinical and Diagnostic Research
anti-tuberculosis treatment
directly observed treatment
drug-induced reaction
mycobacterium tuberculosis
title Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
title_full Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
title_fullStr Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
title_full_unstemmed Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
title_short Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
title_sort rifampicin induced pancytopenia in pulmonary tuberculosis patient a rare presentation
topic anti-tuberculosis treatment
directly observed treatment
drug-induced reaction
mycobacterium tuberculosis
url https://www.jcdr.net/articles/PDF/19102/67726_CE[Ra1]_F(IS)_PF1(KB_SS_OM)_PF_NC(KM)_Ref_Pat(OM)_PN(KM).pdf
work_keys_str_mv AT yashikabansal rifampicininducedpancytopeniainpulmonarytuberculosispatientararepresentation
AT nitintangri rifampicininducedpancytopeniainpulmonarytuberculosispatientararepresentation